Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
147.00
+0.68 (0.46%)
At close: Mar 3, 2026, 4:00 PM EST
147.31
+0.31 (0.21%)
Pre-market: Mar 4, 2026, 9:09 AM EST
Insmed Employees
Insmed had 1,664 employees as of December 31, 2025. The number of employees increased by 393 or 30.92% compared to the previous year.
Employees
1,664
Change (1Y)
393
Growth (1Y)
30.92%
Revenue / Employee
$364,437
Profits / Employee
-$767,293
Market Cap
31.69B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,664 | 393 | 30.92% |
| Dec 31, 2024 | 1,271 | 359 | 39.36% |
| Dec 31, 2023 | 912 | 176 | 23.91% |
| Dec 31, 2022 | 736 | 123 | 20.07% |
| Dec 31, 2021 | 613 | 92 | 17.66% |
| Dec 31, 2020 | 521 | 86 | 19.77% |
| Dec 31, 2019 | 435 | 62 | 16.62% |
| Dec 31, 2018 | 373 | 159 | 74.30% |
| Dec 31, 2017 | 214 | 53 | 32.92% |
| Dec 31, 2016 | 161 | 36 | 28.80% |
| Dec 31, 2015 | 125 | 36 | 40.45% |
| Dec 31, 2014 | 89 | 28 | 45.90% |
| Dec 31, 2013 | 61 | 20 | 48.78% |
| Dec 31, 2012 | 41 | -1 | -2.38% |
| Dec 31, 2011 | 42 | 2 | 5.00% |
| Dec 31, 2010 | 40 | 25 | 166.67% |
| Dec 31, 2009 | 15 | -82 | -84.54% |
| Dec 31, 2008 | 97 | 3 | 3.19% |
| Dec 31, 2007 | 94 | -63 | -40.13% |
| Dec 31, 2006 | 157 | 72 | 84.71% |
| Dec 31, 2005 | 85 | 30 | 54.55% |
| Dec 31, 2004 | 55 | 35 | 175.00% |
| Dec 31, 2003 | 20 | -3 | -13.04% |
| Dec 31, 2002 | 23 | -37 | -61.67% |
| Dec 31, 2001 | 60 | 20 | 50.00% |
| Dec 31, 2000 | 40 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 6,772 |
| Moderna | 4,700 |
| Genmab | 2,973 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,599 |
| Ascendis Pharma | 1,189 |
INSM News
- 23 hours ago - Baron Health Care Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 1 day ago - Insmed Incorporated (INSM) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 6 days ago - Artisan Global Discovery Fund Q4 2025 Winners, Laggards, Buys & Sells - Seeking Alpha
- 12 days ago - Insmed Incorporated (INSM) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 19 days ago - Insmed To Present at March 2026 Investor Conferences - PRNewsWire
- 27 days ago - Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026 - PRNewsWire
- 4 weeks ago - Insmed: A Brensocatib Pipeline Setback Is Masking A Dupixent-Like Launch - Seeking Alpha